Project Grant HT94252410383
Award Date
6/1/24
Completion Date
5/31/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
This federal Project Grant award in the amount of $2,399,874.00 was issued by the Defense Health Agency, a component of the Department of the Army, under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives at Vanderbilt University Medical Center (VUMC) focused on "Decoding the Inflammatory Spark and Fire: Unraveling the Molecular Basis of Post-Injury Syndrome and Mineralization Disorders." The 4-year...
The Department of the Army Medical Command awarded Vanderbilt University Medical Center (VUMC) a $1,310,914 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on monitoring peripheral immunity to chemotherapy and immunotherapy in breast cancer. The 3-year award, which began on February 1, 2024, aims to advance the understanding of biomarkers and identify novel therapies for breast cancer treatment. As a leading academic medical center with...
The Department of the Army Medical Command has awarded a $2,264,623 Project Grant to Vanderbilt University Medical Center (VUMC) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research on toxicant-mediated pulmonary hypertension in Southwest Asia veterans. The project will be conducted over a 4-year period from May 1, 2025 to April 30, 2029. VUMC, a prominent academic medical center and non-profit healthcare...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $525,000 Project Grant to Vanderbilt University Medical Center to investigate novel mechanisms of ovarian cancer initiation in the fallopian tube. The award, effective April 1, 2024 through March 31, 2026, supports biomedical research aimed at improving the health and care of military service members, veterans, and their families. As a sub-award under this grant, Vanderbilt University's...
This Project Grant award for $158,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports research at Vanderbilt University focused on "METABOTROPIC GLUTAMATE RECEPTOR 7 AND LEARNING IN NF1". The award period runs from June 1, 2025 to May 31, 2027. Vanderbilt University, a leading private research institution, will conduct this research project to explore innovative approaches to...
Vanderbilt University Medical Center was awarded a $1,727,296 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from February 15, 2022 to February 14, 2025 to assess the role of intracellular parathyroid hormone-related protein signaling in mechanisms of tumor dormancy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The Department of the Army Medical Command awarded a $782,955.27 Project Grant to Vanderbilt University Medical Center on September 15, 2022, with a completion date of September 14, 2025. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to modulate lung and bone microenvironments to treat breast cancer metastases. The program aims to transform military and public health through innovative biomedical research solutions for battlefield...
The U.S. Department of the Army Medical Command has awarded a $700,000 Cooperative Agreement to Vanderbilt University Medical Center (VUMC) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, titled "KIDNEY CANCER CLINICAL TRIALS CONSORTIUM," will fund advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The project period runs from September 15, 2024 to September...
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...